Search for Clinical Trial Results

Sponsored By

Inclusion Body Myositis - 25 Studies Found

Status Study
Completed Study Name: Arimoclomol in Sporadic Inclusion Body Myositis
Condition: Inclusion Body Myositis
Date: 2008-10-08
Interventions:
  • Drug: Arimoclomol Arimoclomol

Completed Study Name: Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
Condition: Sporadic Inclusion Body Myositis
Date: 2011-08-12
Interventions:
  • Biological: BYM338
  • Biological: Placebo
Completed Study Name: Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis
Condition: Sporadic Inclusion Body Myositis (sIBM)
Date: 2014-03-20
Interventions: Drug: BYM338 (Bimagrumab)
Completed Study Name: Lithium in Inclusion Body Myositis (IBM)
Condition: Inclusion Body Myositis
Date: 2009-06-08
Not yet recruiting Study Name: Study of Arimoclomol in Inclusion Body Myositis (IBM)
Condition: Inclusion Body Myositis
Date: 2016-04-25
Interventions:
  • Drug: Arimoclomol 2 200mg pill
Completed Study Name: Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis
Condition: Inclusion Body Myositis
Date: 2009-05-11
Completed Study Name: Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
Condition: Inclusion Body Myositis
Date: 2008-12-04
Interventions: Drug: Etanercept 50 milligrams subcutaneously every week
Active, not recruiting Study Name: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203
Condition: Sporadic Inclusion Body Myositis
Date: 2015-07-09
Interventions:
  • Drug: Bimagrumab Other Name: B
Completed Study Name: Blood-flow Restricted Exercise in Inclusion Body Myositis
Condition: Sporadic Inclusion Body Myositis
Date: 2014-12-10
Interventions:
  • Other: Blood-flow restricted training

Active, not recruiting Study Name: Natalizumab in Inclusion Body Myositis (IBM)
Condition: Inclusion Body Myositis (IBM)
Date: 2013-05-31
Interventions: Drug: Natalizumab Other Name: Tysabri
Next >>>